Lymphocytes infiltrating ovarian carcinoma: modulation of functional activity by intraperitoneal treatment with biological response modifiers. 1988

P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
Laboratory of Human Immunology, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

A better understanding of the immunobiology of tumor-associated lymphocytes (TAL) may have considerable bearing on the therapeutic perspective of human neoplasia. We have identified ovarian cancer as a clinical condition privileged for studies on immunity and its in vitro and in vivo modulation. Our previous studies on the mechanisms of natural resistance have shown that TAL from ovarian carcinoma have defective natural killer cell activity when compared to peripheral blood lymphocytes from the same patient. This low natural killer cell activity could be stimulated in vitro by biological response modifiers (e.g. interferons) and these findings led us and others to design clinical trials based on intraperitoneal infusions of these agents. Interleukin-2 was extremely effective at inducing or augmenting cytotoxicity in TAL (lymphokine-activated killer cell activity). TAL-generated lymphokine-activated killer cells were cytotoxic against autologous and allogeneic fresh carcinoma cells. This finding provides a rationale for direct intraperitoneal infusion of this cytokine in ovarian cancer.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
January 1991, International journal of immunopharmacology,
P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
January 1989, Anticancer research,
P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
October 1986, Immunopharmacology,
P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
January 1985, Journal of immunopharmacology,
P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
October 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy,
P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
October 1995, Journal of the National Cancer Institute,
P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
January 1987, Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc,
P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
January 1988, Natural immunity and cell growth regulation,
P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
August 1989, [Rinsho ketsueki] The Japanese journal of clinical hematology,
P Allavena, and G Peri, and M Di Bello, and F Peccatori, and F Chiaffarino, and P Pirovano, and A Mantovani
January 1989, Gan no rinsho. Japan journal of cancer clinics,
Copied contents to your clipboard!